medigraphic.com
Colegio de Medicina Interna de México.

2008, Number 6

<< Back Next >>

Med Int Mex 2008; 24 (6)

IL-6 seric determination and PCR qualitative test in subjects with herpes simplex virus positive IgM

Gutiérrez SJ, Carmona GR, Cruz TL

Language: Spanish
References: 30
Page: 381-388
PDF size: 192.59 Kb.


ABSTRACT

Background: Herpes simplex virus (HSV-1 and HSV-2) infection can remain in latent state and re-activate itself with or without clinical symptoms; due to this, several laboratory tests should be done to detect this type of infection.
Objective: To determine seric levels of interleukin-6 (IL-6) and made PCR probe in subjects with IgM positive to HSV.
Material and methods: Eighteen serum samples from subjects with IgM positive for herpes simplex virus (HSV-1 and HSV-2) were analyzed. Serum levels of IL-6 were determined by ELISA test and a qualitative PCR test for HSV detection was carried out. Control group has 20 seemingly healthy subjects with negative levels of immunoglobulins for HSV.
Results: IgM index in serum of subjects with HSV was 1.767 ± 0. 748 and all had negative PCR test. In comparison to control group, group with HSV had a high seric concentration of IL-6 (36.11 ± 5.27 vs 121.9 ± 23.91 pg/mL; p ‹ 0.001; respectively). IL-6 shows a positive correlation with seric levels of IgM (r = 0.668; p ‹ 0.0024).
Conclusion: Negative result in PCR test of all subjects with high serum levels of IgM for HSV indicates the presence of an infection without circulating virus. On the other hand, high levels of IL-6 in this type of subjects show the presence of an inflammatory process with an important correlation with the IgM levels in serum. All at once indicates an infectious process caused by this type of virus. All at once indicates an infectious process caused by this type of virus.


REFERENCES

  1. Corey L, Spear PG. Infections with herpes simplex viruses. N Engl J Med 1986;314:686-91.

  2. Conde-González CJ, Juárez-Figueroa L, Uribe-Salas F, Hernández-Nevárez P, Schmid DS. Analysis of herpes simplex virus 1 and 2 infection in women with high risk sexual behaviour in Mexico. Int J Epidemiol 1999;28;571-76.

  3. www.salud.gob.mx/unidades/conasida.

  4. Conde-González CJ, Lazcano-Ponce E, Hernández-Giró C, Juárez-Figueroa L, Schmid JS. Seroprevalencia de la infección por el virus herpes simplex tipo 2 en tres grupos poblacionales de la ciudad de México. Salud Pública Mex 2003;45(supl)5: S608-16.

  5. Stamm WE, Handsfiel HH, Rompalo AM, Ashely RL, Roberts PL. Association between genital ulcer disease and acquisition of HIV infection in homosexual men. J Am Med Assoc 1988;260:1429-33.

  6. Hook EW, Cannon RQ, Nahmias AJ, Lee FF. Herpes simplex virus infection as a risk factor for HIV infection in heterosexuals. J Infect Dis 1992;165:251-55.

  7. Johnson RE, Nahmias AJ, Magdar LS, Lee CA. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1990;321:7- 12.

  8. Wald A, Corey L, ConeR, Hobson A, Davis G. Frequent genital hepres simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997;99:1092-97.

  9. Marin J, Kese D, Potocnik M, Butina R. Laboratory diagnosis of herpesviruses. Acta Dermatovenerol APA 2000;9:1- 7.

  10. Marin J. The role of herpes simplex virus and human papillomaviruses in triggering malignancy. Acta Dermatovenerol APA 1995;3:95-98.

  11. Llabaca Pavéz G. Síndrome de TORCH. Edición del Servicio de Neonatología del Hospital Clínico; Capítulo 21, Universidad de Chile, 2001;pp:149-67.

  12. Dobec M, Bossart W, Kaeppeli F, Mueller-Schoop J. Serology and serum DNA detection in shingles. Swiss Med Wkly 2008;138:47-51.

  13. Quinlivan M, Breuer J. Molecular studies of varicella zoster virus. Rev Med Virol 2006;16:225-50.

  14. Dickerson FB, Boronow JJ, Stalling C, Origoni AE, Ruslanova I, et al. Association of serum antibodies to herpes simplex virus 1 with congnitive deficits in individuals with schizophrenia. Arch Gen Psychiatry 2003;60:466-72.

  15. Markine-Goriaynoff D, Nguyen TD, Bigaignon G, VanStnick J, Coutelier JP. Distinct reqirements for IL-6 in polyclonal and specific Ig production induced by microorganisms. Inter Immunol 2001;13:1185-92.

  16. Grau GE, Frei K, Piguet PF, et al. Interleukin-6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J Exp Med 1990;172:1505-08.

  17. Lin CH, Hsieh CC, Chen SJ, Wu TC. The diagnositic value of serum interleukin 6 and 8 in children with acute gastroenteritis. J Pediatric Gastroenterol Nut 2006;43:25-29.

  18. Zhang Y, Li J, Zhang Y, Wu L, Yu X. Analisis of serum citokines in patients with severe acute respiratory syndrome. Infec Immmunity 2004;4410-15.

  19. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New England J Med 199;11:448- 54.

  20. Couderc R, Mary R, Veinber F. Marcadores de inflamación en pediatría. Acta Bioquím Clín Latinoam 2004;38:513- 17.

  21. Paludan SR. Requirements for the induction of interleukin-6 by herpes simpex virus-infected leukocytes. J Virol 2001;75:8008- 15.

  22. Stumpf TH, Case R, Shimeld C, Easty DL, Hill TJ. Primary herpes simpex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids. J Gen Virol 2002;83:1579-90.

  23. Persaud D, Zhou Y, Siliciano JM, Siliciano F. Latency in human immunodefciency virus type 1 infection: no easy answere. J Virol 2003;77:1659-65.

  24. Hilleman MR. Strategies and mechanisms for host and pathogen survidal in acute and persistent viral infection. Proc Natl Acad Sci USA 2004;101(supl 2)14560-66.

  25. Wucherpfennig KW. Mechanisms for the induction of autoimmunity my infectious agents. J Clin Invest 2001;108:1097- 104.

  26. Cook WJ, Kramer MF, Walker RM, Burwell TJ. Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simprex virus 1 infection. Virol J. 2004;15:1-12

  27. Koelle DM, Corey L. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev 2003;16:96-113.

  28. Verjans GMGM, Hintzen RQ, vanDum JM, Poot A. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci USA 2007;104:3496-501.

  29. Mogensen TH, Paludan SR. Molecular pathways in virus- induced cytokine production. Microbiol Mol Biol Rev 2001;65:131-50.

  30. Novak N, Peng WM. Dancing with the enemy: the interplay of herpes simpex virus with dendritic cells. Clin Exp Immunol 2005;142:405-10.




2020     |     www.medigraphic.com